Liver News and Research

RSS

Study reveals spatial patterns of alcohol‐related mortality in post-Soviet countries

In some former Soviet bloc countries, men often die early due to alcohol abuse. Alcoholism-related mortality varies considerably from one region to another, according to a study in the European part of Russia, Belarus, Lithuania and Poland.

12 Mar 2020

Low-dose aspirin linked to lower risk of hepatocellular carcinoma and liver-related mortality

Among adults at high risk of liver cancer, those who took low-dose aspirin were less likely to develop the disease or to die from liver-related causes.

12 Mar 2020

Researchers uncover clues to how statins kill cancer cells

More than 35 million Americans take statin drugs daily to lower their blood cholesterol levels. Now, in experiments with human cells in the laboratory, researchers at Johns Hopkins Medicine have added to growing evidence that the ubiquitous drug may kill cancer cells and have uncovered clues to how they do it.

12 Mar 2020

Immunosuppressive therapy does not increase risk of vulvar or vaginal cancer in women with IBD

In a new retrospective study, researchers found that the use of immunosuppressive therapy does not increase the occurrence or recurrence of vulvar or vaginal cancer in women with inflammatory bowel disease (IBD).

11 Mar 2020

Popular painkiller may have more significant effects on the liver than expected

The popular painkiller ibuprofen may have more significant effects on the liver than previously thought, according to new research from the University of California, Davis.

11 Mar 2020

Researchers discover human protein that potently inhibits coronavirus

A protein produced by the human immune system can potently inhibit several coronaviruses, including the one behind the current COVID-19 outbreak, an international team of investigators reports today. The research reveals that the LY6E protein impairs the coronavirus' ability to initiate infection, which could lead to treatments for the illness.

10 Mar 2020

Cream infused with microscopic STAR particles could facilitate better treatment of skin diseases

Skin diseases affect half of the world's population, but many treatments are not effective, require frequent injections, or cause significant side effects.

10 Mar 2020

New imaging agent illuminates cancerous tumors and surrounding cells

Scientists at Washington University School of Medicine in St. Louis have developed a new imaging agent that could let doctors identify not only multiple types of tumors but the surrounding normal cells that the cancer takes over and uses as a shield to protect itself from attempts to destroy it.

10 Mar 2020

Family ties and traits key to survival in parasitic organisms

New research by Texas A&M University biologist Dr. Charles Criscione and collaborators in Canada shows that family ties and traits such as manipulation, sacrifice and selflessness are just as key to survival in parasitic organisms as they are in cognitive species like humans.

10 Mar 2020

Combination of anti-cancer nanodrugs with Intralipid enhances therapeutic efficacy

Pairing chemotherapy nanodrugs with a nutritional supplement can lessen devastating side-effects while reducing the amount of the expensive drugs needed to treat cancer according to a study from Carnegie Mellon University and Taiwan's National Health Research Institutes.

10 Mar 2020

A copper-binding protein influences breast cancer cell migration

Researchers at Chalmers University of Technology, Sweden, have shown that the Atox1 protein, found in breast cancer cells, participates in the process by which cancer cells metastasise.

10 Mar 2020

How effective is Gabapentin in alcohol use disorder?

A new study published in the journal JAMA Internal Medicine in March 2020 reports the striking efficacy of the drug gabapentin in helping people with alcohol use disorder (AUD) with their alcohol withdrawal symptoms.

9 Mar 2020

Bacteria may be involved in the development of type 2 diabetes, study shows

Bacteria may be involved in the development of type 2 diabetes, according to a study published today in Nature Metabolism by researchers from Université Laval, the Québec Heart and Lung Institute, and McMaster University.

9 Mar 2020

Levels of sBTLA proteins may be a marker of overall survival in patients with HCC

In the 2020 February 25 issue of Scientific Reports, a research group from the Department of Hepatology in Osaka City University Graduate School of Medicine, Japan reported that levels of a circulating soluble immune checkpoint protein can be used as a potential marker to predict overall survival in patients with advanced HCC.

9 Mar 2020

Liver fibrosis associated with one type of heart failure, regardless of HIV or hepatitis C status

While there is an association between liver fibrosis and heart failure, the mechanisms for this association are currently unclear but may be of particular importance for people living with human immunodeficiency virus (HIV) and/or hepatitis C, both of which are chronic infections that affect the liver and heart.

7 Mar 2020

Gastrointestinal manifestations and fecal-oral transmission of novel coronavirus

The world is bracing for the impact of the novel coronavirus, COVID-19, which has now spread to over 30 countries, infecting more than 80,000 people with over 2,600 deaths globally. A better understanding of how this virus is transmitted is key to preventing its spread.

5 Mar 2020

Automated CT-based biomarkers can better predict cardiovascular events than standard methods

Researchers at the National Institutes of Health and the University of Wisconsin have demonstrated that using artificial intelligence to analyze CT scans can produce more accurate risk assessment for major cardiovascular events than current, standard methods such as the Framingham risk score and body-mass index.

5 Mar 2020

Type 2 diabetes mellitus responds to weight loss surgery

Type 2 diabetes mellitus (T2DM) is a metabolic condition with close links to weight gain. Since weight loss is a proven way to control T2DM, it is to be expected that surgeries to achieve weight loss should result in better regulation of blood glucose levels.

4 Mar 2020

Yale discovery has implications for treatment of diabetes and non-alcoholic fatty liver disease

Many health problems in the developed world stem from the disruption of a delicate metabolic balance between glucose production and energy utilization in the liver.

4 Mar 2020

Novel compounds show promise as potent new treatment for malaria

A novel class of antimalarial compounds that can effectively kill malaria parasites has been developed by Australian and US researchers.

4 Mar 2020

Liver News and Research

Study reveals spatial patterns of alcohol‐related mortality in post-Soviet countries

Low-dose aspirin linked to lower risk of hepatocellular carcinoma and liver-related mortality

Researchers uncover clues to how statins kill cancer cells

Immunosuppressive therapy does not increase risk of vulvar or vaginal cancer in women with IBD

Popular painkiller may have more significant effects on the liver than expected

Researchers discover human protein that potently inhibits coronavirus

Cream infused with microscopic STAR particles could facilitate better treatment of skin diseases

New imaging agent illuminates cancerous tumors and surrounding cells

Family ties and traits key to survival in parasitic organisms

Combination of anti-cancer nanodrugs with Intralipid enhances therapeutic efficacy

A copper-binding protein influences breast cancer cell migration

How effective is Gabapentin in alcohol use disorder?

Bacteria may be involved in the development of type 2 diabetes, study shows

Levels of sBTLA proteins may be a marker of overall survival in patients with HCC

Liver fibrosis associated with one type of heart failure, regardless of HIV or hepatitis C status

Gastrointestinal manifestations and fecal-oral transmission of novel coronavirus

Automated CT-based biomarkers can better predict cardiovascular events than standard methods

Type 2 diabetes mellitus responds to weight loss surgery

Yale discovery has implications for treatment of diabetes and non-alcoholic fatty liver disease

Novel compounds show promise as potent new treatment for malaria

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News